? Comparison of cinnarizine and betahistine in the treatment of peripheral vertigo

Vice chancellor for research, Shahrekord University of Medical Sciences0 个研究点目标入组 170 人开始时间: 待定最近更新: 2019年10月7日

适应症

试验速览

暂无简介。

•Age 18-65 years old
•Having symptoms of vertigo for at least two months
•Non-sensitivity to cinnarizine and betahistine
•Natural Signs and Natural Nerve Findings
•Failure to receive vertigo control drugs at least 7 days before
•There is no evidence of the causes of central vertigo in a CT scan performed by a patient before the start of the study

•Patients with abnormal vital signs, kidney failure, liver disease, heart disease, active stomach ulcer disease or diabetes
•Patients with ulcerative diagnosis of vertigo with central causes
•Brain traumatic brain injury
•Concomitant use of hypertension drugs such as thiazide, antihistamines, corticosteroids and calcium channel antagonists.
•Patients who are being treated for benzodiazepines for any reason
•Patients who have received anti-vertigo during the last week
•The sensitivity of the drug to cinnarizine and betahistine
•Those who are pregnant or breastfeeding
•People who are not satisfied with the study

发起方

Vice chancellor for research, Shahrekord University of Medical Sciences